Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells-Reference-Cited by-同舟云学术

Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells

Published:2007-06 Issue:2 Volume:250 Page:194-205
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Benassi Maria Serena,Chiechi Antonella,Ponticelli Francesca,Pazzaglia Laura,Gamberi Gabriella,Zanella Licciana,Manara Maria Cristina,Perego Paola,Ferrari Stefano,Picci Piero

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Classic Osteosarcoma;Campanacci,1999

2. Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma;Hauben;Eur. J. Human Genetics,2003

3. Intensification of preoperative chemotherapy for osteogenic sarcoma: the results of the Memorial Sloan-Kettering (T12) protocol;Meyers;J. Clin. Oncol.,1998

4. Neoadjuvant chemotherapy for extremity osteosarcoma. Preliminary results of the Rizzoli’s 4th study;Bacci;Acta Oncol,1998

5. Prognostic factors in high grade Osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols;Bielack;J. Clin. Oncol.,2002

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‑metastatic activity of aromatic aminomethylidenebisphosphonates in a mouse model of 4T1 cell‑derived breast cancer;Oncology Reports;2023-05-18

2. Bisphosphonates in common pediatric and adult bone sarcomas;Bone;2020-10

3. New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma;Pharmacology & Therapeutics;2020-10

4. Bisphosphonates—much more than only drugs for bone diseases;European Journal of Pharmacology;2020-01

5. Cisplatin bioconjugated enzymatic GNPs amplify the effect of cisplatin with acquiescence;Scientific Reports;2019-09-25